Skip To Content

ACD/Labs Blog

ACDLabs
In this study the crystallographic structure of the interaction between SARSCoV-2 (RBD) and ACE2 was used to determine compounds that could reduce the interaction between SARS-CoV-2 and ACE2; with these results compounds will be proposed to develop a new drug against COVID-19. PhysChem Suite was used to predict chemical properties of the compounds including toxicity,...

ACDLabs
v2021 of ACD/Labs’ Spectrus and Percepta platform applications provide updates and new software features for its desktop and enterprise products Toronto, CANADA (September 21, 2021)—ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced its annual updates across its Spectrus and Percepta platform applications. “The increasing degree of proximity-limited scientific research...

ACDLabs
To use network pharmacology and molecular docking technology in predicting the main active ingredients and targets of Qushi Huayu Decoction treatment in Nonalcoholic Fatty Liver Disease and explore the potential mechanisms of its multi-component-multi-target-multi-pathway. Materials and Methods. The main chemical components of QHD were searched using traditional Chinese medicine system pharmacology technology platform and PubChem...

ACDLabs
V2020.1 offers a number of updates to the Spectrus and Percepta platforms Toronto, CANADA (September 23, 2020)—ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced its annual updates across its Spectrus and Percepta platform applications. “With many scientists working both remotely and in shifts, there has been an increased...

ACDLabs
Due to the COVID-19 pandemic, flexibility in work hours and location remains a reality for many ACD/Labs software users. With ongoing travel restrictions, the need for online collaboration and remote access to scientific data continues to be a focus for many R&D organizations. ACD/Labs’ COVID-19 Response ACD/Labs is committed to providing our customers and partners...

Sherry Myles
Software enhancements offer a complete application for CMC decision support, improvements for analytical data processing and analysis, and a move to 64-bit architecture. Toronto, Canada (Sept. 18, 2019)—ACD/Labs, an informatics company that develops and commercializes analytical and chemical knowledge management solutions in support of R&D, today announced significant updates across its Spectrus and Percepta platforms...

ACDLabs
This guide to informatics and data integrity published by the European Pharmaceutical Review highlights ACD/Labs software solutions including our Spectrus and Percepta platforms, and new solutions Luminata and Katalysts D2D.

Sherry Myles
New web-based technology facilitates ease of deployment and support for IT while continuing to deliver ACD/Labs’ industry leading physicochemical, ADME, and toxicity calculators to scientists Toronto, Canada (May 8, 2019)—ACD/Labs, an informatics company that is celebrating 25 years of providing chemical and analytical knowledge management solutions for R&D, announced the launch of a web-based application—Percepta...